Key facts
- This page summarizes Robert Nelsen's Form 4 filing for Vir Biotechnology, Inc. (VIR).
- 8 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 01 Sep 2022, 17:22.
Robert Nelsen - 30 Aug 2022 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)
- Reporting relationship
- Director, 10%+ Owner
- Issuer ticker
- VIR
- Reported as of
- 30 Aug 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 01 Sep 2022, 17:22:25 UTC
- Prior SEC filing
- 26 Aug 2022
- Next SEC filing
- 07 Sep 2022
- Source filing
- View source filing
- Reporting owner signature
- By: Robert Nelsen, Managing Director, By: /s/ Mark McDonnell, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert Nelsen filed Form 4 for Vir Biotechnology, Inc. (VIR) on 01 Sep 2022.
Change
- Previous filing in this sequence was filed on 26 Aug 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VIR
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- -217,781
- Change %
- -3.4%
- Price
- $0.000000
- Shares after
- 6,279,351
- Date
- 30 Aug 2022
- Ownership
- See footnote
- Footnotes
- F1, F2
VIR
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- -282,219
- Change %
- -3.4%
- Price
- $0.000000
- Shares after
- 8,137,312
- Date
- 30 Aug 2022
- Ownership
- See footnote
- Footnotes
- F1, F3
VIR
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- +27,489
- Change %
- +6%
- Price
- $0.000000
- Shares after
- 487,657
- Date
- 30 Aug 2022
- Ownership
- Direct
- Footnotes
- F1, F4
VIR
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- +1,684
- Change %
- +6.2%
- Price
- $0.000000
- Shares after
- 28,851
- Date
- 30 Aug 2022
- Ownership
- See footnote
- Footnotes
- F1, F4, F5
VIR
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- -217,781
- Change %
- -3.5%
- Price
- $0.000000
- Shares after
- 6,061,570
- Date
- 31 Aug 2022
- Ownership
- See footnote
- Footnotes
- F1, F2
VIR
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- -282,219
- Change %
- -3.5%
- Price
- $0.000000
- Shares after
- 7,855,093
- Date
- 31 Aug 2022
- Ownership
- See footnote
- Footnotes
- F1, F3
VIR
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- +27,489
- Change %
- +5.6%
- Price
- $0.000000
- Shares after
- 515,146
- Date
- 31 Aug 2022
- Ownership
- Direct
- Footnotes
- F1, F4
VIR
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- +1,684
- Change %
- +5.8%
- Price
- $0.000000
- Shares after
- 30,535
- Date
- 31 Aug 2022
- Ownership
- See footnote
- Footnotes
- F1, F4, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Distribution of Common Stock held by a limited partnership to its partners for no consideration.
Footnote F2
The shares are held by ARCH Venture Fund IX, L.P. ("ARCH IX"). The Reporting Person is a managing director of ARCH Venture Partners IX, LLC, the sole general partner of ARCH Venture Partners IX, L.P., which is the sole general partner of ARCH IX, and shares voting and investment control with respect to shares held by ARCH IX. The Reporting Person may be deemed to beneficially own the shares held by ARCH IX, and the Reporting Person disclaims ownership of such shares, except to the extent of his pecuniary interest therein.
Footnote F3
The shares are directly held by ARCH Venture Fund IX Overage, L.P. ("ARCH Overage"). The Reporting Person is a managing director of ARCH Venture Partners IX, LLC, the sole general partner of ARCH Venture Partners IX Overage, L.P. ("Overage GPLP"), which is the sole general partner of ARCH Overage, and shares voting and investment control with respect to shares held by ARCH Overage. The Reporting Person disclaims ownership of such shares, except to the extent of his pecuniary interest therein.
Footnote F4
Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person.
Footnote F5
Shares held by a trust for the benefit of family members of the Reporting Person.